AIKON
9 known investors
Find your way into AIKON
AIKON Health develops a wearable device solution for heart failure monitoring that measures vital parameters such as fluid retention, cardiac output, and stroke volume to help cardiologists and cardiology nurses manage patients and reduce hospital readmissions. The solution enables continuous tracking from hospital discharge through at-home care with digital biomarkers to identify early deterioration.
Investors · 9
BOMTilburg · $540K – $5.4M
Alpha EdisonreportedLos Angeles · $1M – $10M
Blizzard the AvalanchereportedNew York
Mighty CapitalreportedSan Francisco
Think+ Ventures Management, LlcreportedPalo Alto · $200K – $500K
Up2reportedCleveland
Yugen Partnersreported
Also in the syndicate · 2
Hestia InvestmentsMorgan Creek Digitallead
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ASep 2022
Morgan Creek Digital (lead), Alpha Edison, Blizzard the Avalanche Fund, Hestia Investments, Mighty Capital, Think+ Ventures, Up2 Opportunity Fund, Yugen Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does AIKON do?
- AIKON Health develops a wearable device solution for heart failure monitoring that measures vital parameters such as fluid retention, cardiac output, and stroke volume to help cardiologists and cardiology nurses manage patients and reduce hospital readmissions. The solution enables continuous tracking from hospital discharge through at-home care with digital biomarkers to identify early deterioration.
- Who are AIKON's investors?
- AIKON's investors include BOM, Alpha Edison, Blizzard the Avalanche, Mighty Capital, Think+ Ventures Management, Llc, Up2, Yugen Partners.